Vertex Pharmaceuticals Incorporated
USD428.34
+3.25 (+0.76%)
CEO
Reshma Kewalramani
IPO Date
1991-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$420.01
Prev. Close
$425.09
Day Low
$420.01
Day High
$429.01
52W Low
$362.50
52W High
$507.92
Market Cap
$108.72B
Volume
1.32M
| -193.6 |
| 31 Dec 2023 | FY | 87.2% | 36.7% | 20.6% | 15.9% | 0.05 | 3.99 | 29.0 |
| 31 Dec 2022 | FY | 87.9% | 37.2% | 23.9% | 18.3% | 0.04 | 5.22 | 22.3 |
| 31 Dec 2021 | FY | 88.1% | 30.9% | 23.2% | 17.4% | 0.06 | 4.81 | 24.2 |
| 31 Dec 2020 | FY | 88.1% | 43.7% | 31.2% | 23.1% | 0.07 | 5.02 | 22.6 |
| 31 Dec 2019 | FY | 86.8% | 28.3% | 19.3% | 14.1% | 0.10 | 3.83 | 47.8 |
| 31 Dec 2018 | FY | 86.6% | 68.8% | 47.3% | 33.6% | 0.13 | 5.17 | 20.1 |
| 31 Dec 2017 | FY | 88.9% | 10.6% | 12.9% | 7.4% | 0.29 | 3.08 | 141.5 |
| 31 Dec 2016 | FY | 87.6% | -6.6% | -8.4% | -3.9% | 0.87 | 221.40 | -160.9 |
| 23.1 |
| 30 Jun 2025 | Q2 | 86.3% | 34.8% | 6.0% | 4.3% | 0.09 | 2.52 | 27.7 |
| 31 Mar 2025 | Q1 | 86.9% | 23.3% | 3.9% | 2.8% | 0.10 | 2.65 | 48.2 |
| 31 Dec 2024 | Q4 | 85.5% | 31.4% | 5.6% | 4.1% | 0.11 | 2.69 | 28.4 |
| 30 Sept 2024 | Q3 | 85.8% | 37.7% | 6.7% | 4.7% | 0.11 | 2.47 | 28.7 |
| 30 Jun 2024 | Q2 | 85.9% | -136.4% | -24.3% | -17.9% | 0.06 | 2.52 | -8.5 |
| 31 Mar 2024 | Q1 | 87.3% | 40.9% | 5.9% | 4.6% | 0.04 | 3.50 | 24.7 |
| 31 Dec 2023 | Q4 | 85.4% | 38.5% | 5.5% | 4.3% | 0.05 | 3.99 | 27.1 |
| 30 Sept 2023 | Q3 | 87.2% | 41.7% | 6.3% | 4.8% | 0.05 | 4.08 | 21.7 |